FDA Updates

New Rx, indications, generics, OTC, and devices.

The 2013-2014 influenza season is the first time that quadrivalent influenza vaccines will be available in the United States. They are shipping now.

Hair treatments, shampoos and conditioners, and more.

New Rx, indications, generics, and OTC

August is a great time for many families to enjoy the outdoors before school starts. Anyone preparing for a camping trip, a hike, a boating adventure, biking, or just swimming should prepare a first aid kit for any unexpected mishaps. Some new items to add to the kit are described below.

FDA approved levomilnacipran extended-release capsules (Fetzima) for the treatment of major depressive disorder (MDD) in adults, according to the manufacturers, Forest Laboratories and Pierre Fabre Laboratories.

New Rx, indications, generics, and OTC for pharmacists

McKesson has released a mobile application it says can help improve medication adherence rates, help pharmacies operate more efficiently, and reduce hospital admissions.

The U.S. Supreme Court today ruled that pay-for-delay agreements between brand name drug companies and generic manufacturers are subject to antitrust scrutiny.

Skin-care products for safe fun in the sun

New Rx, Generics, and OTC

Aceto Corporation, Port Washington, N.Y., announced June 11 that its generics subsidiary, Rising Pharmaceuticals Inc., Paramus, N.J., will launch the 50-mg strength of riluzole tablets.

Sandoz has become the first company to gain the FDA approval to produce a generic version of Atacand (candesartan cilexetil).

New Rx, generic, indication, and OTC

FDA approved a new fixed-dose combination ophthalmic suspension of a carbonic anhydrase inhibitor (brinzolamide 1.0%) and an alpha 2 adrenergic receptor agonist (brimonidine tartrate 0.2%), which is indicated for the reduction of intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.

FDA has approved a supplemental new drug application (sNDA) for lubiprostone (Amitiza, Sucampo Pharmaceuticals and Takeda Pharmaceuticals) 24 ?g twice daily as the first oral medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, noncancer pain.

The popular guide by Harold Silverman, PhD, is now available as an app for iPhones, iPods, and iPads

Built-in timer notes when bottle was last opened

Topical products for pain relief

New Rx, generics, OTC, and devices

The third edition of APhA's pocket reference is now available

The third edition of "Peripheral Brain for the Pharmacist" is now available

A survey of new Rx, new generic, and new OTC products

A survey of new Rx, new generic, and new OTC products